Evis Hursever, Ph.D.

Managing Director
EW Healthcare Partners

Evis is a Managing Director with EW Healthcare Partners, one of the largest and oldest private equity healthcare firms that is seeking to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. 

Evis has led and served on the Board of Directors of EW growth equity portfolio companies EUSA Pharma, Cognate BioServices and Grupo Biotoscana (acquired by Knight Therapeutics). 

Prior to joining EW in 2011, Evis was a senior manager in the European life sciences and healthcare team at LEK Consulting, a leading management consulting company. She was involved in several large business transactions in the healthcare space, developed growth strategies for several pharmaceutical companies, and led numerous due diligence assignments for private equity firms in the healthcare industry.  Prior to LEK Consulting, Evis worked in the healthcare investment banking team at Merrill Lynch International providing M&A advisory services to a broad range of life sciences and healthcare companies.

Evis received her Ph.D. in Biological Chemistry from University of Pennsylvania and her Bachelor of Arts degree from Macalester College.